- 询价
- 辰辉创聚生物
- 中国
- NBAB-136493
- 2025年07月14日
- IHC-P, WB
企业认证
相关产品推荐更多 >
EIF4A3抗体 | Anti-EIF4A3 Polyclonal Antibody
询价
Swine Influenza H1N1 Hemagglutinin / HA抗体 | Swine Influenza H1N1 Hemagglutinin / HA Monoclonal Antibody
询价
MNAT1抗体 | Anti-MNAT1 Polyclonal Antibody
询价Progranulin单抗 | Anti-Progranulin Monoclonal Antibody
询价H4C1/HIST1H4A抗体 | Anti-H4C1/HIST1H4A Polyclonal Antibody
询价
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原：
Recombinant Human Ig kappa light chain protein
- 形态：
液体
- 保存条件：
Short term 4℃; Long term -20℃.
- 克隆性：
单克隆
- 保质期：
见COA
- 库存：
大量
- 供应商：
辰辉创聚生物
- 应用范围：
IHC-P, WB
- 靶点：
Ig kappa light chain
- 抗体英文名：
Anti-Ig kappa light chain Monoclonal Antibody
- 抗体名：
Ig kappa light chain抗体
- 规格：
100ul; 500ul; 1ml
| 产品信息
品名:NebuSelect™ Anti-Ig kappa light chain Monoclonal Antibody
货号:NBAB-136493
品牌:Nebulabio
规格:100ul; 500ul; 1ml
| 产品描述
| 产品属性
Product Category：Mouse MAb
Reactivity：Human
Specificity：Human Ig kappa light chain
Immunogen：Recombinant Human Ig kappa light chain protein
Isotype：Monoclonal Mouse IgG
Purification：Protein A & Protein G Affinity Purification
Buffer：0.2 μm filtered solution in PBS, pH7.4, containing 0.09% Sodium azide, 50% glycerol.
Conjugate：Unconjugated
Applications：IHC-P, WB
Dilution：IHC-P 1:50～1:500; WB 1:1000～1:5000
Storage：Store at 4°C for short-term, -20°C for long-term. Avoid repeated freezing and thawing cycles.
For Research Use Only!
To get more information, please contact us freely.
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Notes on Making Rat x Y3 Monoclonal Antibody Producing Hybridomas
to the kappa 1a of Y3 (eg. DA which is kappa 1b) to allow later screening of myeloma light chain loss variants (if required). b) The final boost should be by the intravenous route, four days before the fusion, to ensure maximal activity in the spleen.
Humanization and Simultaneous Optimization of Monoclonal Antibody
optimizing the antibody molecule in the light of these properties, it should prove possible to shorten the research and development period necessary to identify a highly qualified clinical candidate and consequently accelerate the start of the clinical trial.
Monoclonal Antibody Lead Characterization: In Vitro and In Vivo Methods
This chapter describes in vitro and in vivo methods to characterize a lead monoclonal antibody candidate in the drug discovery setting. Approaches to characterize monoclonal antibody specificity, heavy and light chain composition
技术资料暂无技术资料 索取技术资料
